Delivery Order SPE2DR25D2106-SPE2DR26F1GAE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,561.75 to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate Extended Release 50 mg tablets (1,000 count) on December 1, 2025, with a completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Metoprolol Succinate Extended-Release 25 mg tablets (1,000 count) on October 17, 2025, with a ceiling value of $2,676.16 and an ultimate completion date of October 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, valued at $1,312.12. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The products will be delivered to Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate Extended Release 100 mg tablets (1,000 count) with a ceiling value of $2,111.66. This competitively awarded, non-set-aside delivery order was finalized on December 9, 2025, with an ultimate completion date of December 10, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for the supply of Metoprolol Succinate Extended Release 25 mg tablets (1,000 count) with a ceiling value of $1,292.79. The contract was awarded on October 28, 2025, with an ultimate completion date of October 29, 2025, utilizing a firm fixed-price structure. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets (100-count bottles) with a ceiling value of $1,239.66. This firm fixed-price delivery order is scheduled for ultimate completion by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,028.79 to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate Extended-Release 25 mg on October 17, 2025, with completion scheduled for October 20, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is fulfilling...
- The Defense Logistics Agency awarded a $3,454.23 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of 1,000 tablets of Metoprolol Succinate Extended-Release 50 mg, with completion scheduled for October 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,182.44 for 1,000 tablets of Metoprolol Succinate Extended-Release 25 mg, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,228.13 to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate Extended Release 50 mg. This competitively awarded contract, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The pharmaceutical product will be delivered to the awardee's place of performance in Conshohocken, Pennsylvania, where...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1GAEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Metoprolol Succinate Extended Release 25 mg tablets in a quantity of 1,000 units, valued at $1,127.04. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by December 18, 2025. The award leverages AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's performance under the DLA framework reflects its capability to fulfill diverse pharmaceutical requirements through competitive procurement processes. This delivery order for the antihypertensive medication exemplifies the routine, mission-critical medical supply fulfillment that sustains military and veteran healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/16/25 |